loading

Finanzdaten der Avenue Therapeutics Inc-Aktie (ATXI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31
Periodenlänge 3 Monate
Research and Development
Operating Income/Loss
Nonoperating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Basic Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
$59.64
price down icon 1.55%
$127.57
price down icon 1.04%
$40.37
price down icon 3.36%
$250.64
price down icon 2.96%
ONC ONC
$342.64
price down icon 2.42%
$203.87
price down icon 1.91%
Kapitalisierung:     |  Volumen (24h):